Board Exam Study Tool (BEST) 2024

David Galbis-Reig MD, FASAM received his Doctor of Medicine degree from Virginia Commonwealth University in Richmond, Virginia in 1999. He completed a residency in Internal Medicine at Aurora Sinai Medical Center in Milwaukee, Wisconsin in 2004. He is board certified in Internal Medicine by the American Board of Internal Medicine and Addiction Medicine by the American Board of Addiction Medicine. He has been the Director of Medical Services on the Inpatient Mental Health and Addiction Unit at Wheaton Franciscan Healthcare – All Saints since 2005 in which capacity he has passionately advocated for appropriate medical treatment of patients with mental health and addictive diseases. Dr. Galbis-Reig is currently also involved in numerous educational activities to decrease prescription drug abuse and decrease the burden of addiction to opioids in Racine and Kenosha Counties. He is an active member of the American Society of Addiction Medicine (ASAM), the current secretary of the Wisconsin Society of Addiction Medicine (WiSAM), and a contributing author to the recently published ASAM white paper on the science of drug testing. He is a member of the Wisconsin Marijuana Prevention Ad-Hoc Committee of the State Council on Alcohol and Other Drug Abuse (SCAODA). He is also an active member of the Wisconsin Medical Society and a member of the Board of Directors of the Wisconsin Medical Society Foundation.

Michael A. Darracq, M.D., MPH, is board certified in Emergency Medicine and Medical Toxicology. He earned his medical degree from University of California, Davis. At UC Davis, he also completed his residency in Emergency Medicine. His fellowship in Medical Toxicology was completed at University of California, San Diego. He earned his Master of Public Health at American Military University.

His professional interests are Emergency Medicine, Critical Care, Medical Toxicology, and Wilderness/Austere Medicine. He currently serves as Associate Professor at the University of California - San Francisco and as Co-President at the American College of Medical Toxicology Recent Graduate Section. 

From 2004 to 2011, Dr. Darracq served in the United States Navy. His position was Staff Emergency Physician and Core Faculty at the Naval Medical Center San Diego Emergency Medicine Residency. Then he was a part of the Forward Deployment in Afghanistan in 2008 to 2009 as an Emergency Medicine Mentor, Afghan National Army.

Dr. Goldsmith began his addiction medicine career in 1974 as a medical student, learning about the disease of alcoholism as a counselor for one of the Department of Transportation's Alcohol Safety Action Projects. He received his medical training and finished his residency in Psychiatry at the University of Cincinnati College of Medicine. Dr. Goldsmith worked in the VA for 15 years, splitting his time between Dual Diagnosis Services, psychiatric consultations and research with the Clinical Trials Network. He was an active member of Cincinnati's NIDA research group, and Cincinnati's principal investigator for its pivotal study of buprenorphine/naloxone for opiate addiction. Dr Goldsmith also created an integrated Primary Care Mental Health program with the director of Primary Care, initiated in 2007 and still active. Prior to retiring, Dr. Goldsmith worked in the VA Buprenorphine Treatment Clinic.

In 1994, Dr. Goldsmith developed an ACGME accredited Addiction Psychiatry Fellowship and the following year was funded by the Dept. of Veterans Affairs for a two year Addiction Medicine Fellowship. He holds the title of Professor of Clinical Psychiatry in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati. He was addiction fellowship director from 1989 to 2007 and continues to teach in addiction fellowships: Psychiatry and ABAM.

Dr. Goldsmith joined ASAM in 1984, became ASAM certified in 1986 and got his CAQ in Addiction Psychiatry in 1994. He has been on the CME committee since then, and was its chair for nine years from 2000-2009. Dr Goldsmith was President of ASAM 2015-2017.

Dr. Soumya L. Pandalai is a board certified physician in the field of Internal Medicine and Addiction Medicine. She currently works at Banner University Medical Center Phoenix (BUMCP) in Phoenix, Arizona as a specialist in Addiction Medicine and provides both inpatient consultation services and outpatient treatmentr to persons with Substance Use Disorders (SUDs). Dr. Pandalai enjoys the clinical practice of Addiction Medicine and finds the neuroscience of addiction to be intellectually stimulating and challenging to observe the health-effects that can result from various aspects of human behavior. It is also immensely rewarding to connect with patients at different stages of their recovery process and help them along their path toward healing. She hopes to inspire people to view addiction from a different lens and apply principles of substance use and reward pathways to general aspects of human motivation and other medical illnesses. Dr. Pandalai is proud and grateful to work with an interdisciplinary team of hospital staff, social workers, counselors and other medical providers to create a more inclusive and health-focused model for substance use treatment, chronic pain and use of treatment options like tele-health to advance the care of vulnerable patient populations.

Dr. Hiroko Furo was born in Japan and is a graduate of Kagawa University, Japan. She received her Ph.D. in Sociolinguistics from Georgetown University in Washington DC, and her medical degree at the University of Illinois at Chicago. She completed her residency training in occupational medicine at the University of Texas at Health NorthEast. She is board certified in addiction medicine and occupational medicine. She is also board eligible for Clinical Informatics and Life Style Medicine.

Dr. Furo is a clinical assistant professor in addiction medicine at the University of Texas Health at San Antonio. Her research interests in addiction medicine are research informatics, computational linguistics and population health.

Dr. Hunter is the Medical Director of Addiction Medicine at United Health Services Hospitals, Inc. (UHS). Under her leadership, her department embraces evidence-based practices and harm reduction principles in its low-threshold buprenorphine program, opioid treatment program, and 20-bed inpatient unit.  She teaches residents at UHS in psychiatry, family medicine, and internal medicine, and is the methadone site director for Geisinger’s addiction medicine fellowship.  She is pleased to participate in the American Society of Addiction Medicine’s Board Exam Study Tool Subcommittee, the New York State Department of Health AIDS Institute Substance Use Guidelines Committee, the New York State Advisory Group on Hepatitis C Treatment Among People Who Inject Drugs, and the New York State Department of Health’s Buprenorphine Working Group.

She is board certified in addiction and family medicine.  She graduated from Harvard University with honors with a bachelor’s in history, and graduated from Dartmouth College with a master of public health. After attending SUNY Upstate Medical University, she completed her family medicine residency at the University of Vermont and her addiction medicine fellowship at Summa Health.

Dr. Ahmed is triple board-certified in Adult Psychiatry and Addiction Psychiatry by the American Board of Psychiatry and Neurology, and in Addiction Medicine by the American Board of Preventive Medicine. He has extensive experience treating psychiatric and substance use disorders in both inpatient and outpatient settings. Additionally, he is actively involved in clinical research and teaching.